‘Challenging’ Times For Sandoz As COVID Bites

Sales And Core Operating Profit See Double-Digit Declines Despite Biopharma Growth

 
• By David Wallace
COVID coronavirus impact graph recovery
Sandoz expects its business to stabilize as pandemic pressures ease • Source: Alamy

More from Earnings

More from Business